Microparticulate delivery systems: Potential drug/vaccine carriers via mucosal routes

Pharmaceutical Science and Technology Today

Volumn 1, Issue 2, 1998, Pages 69-75

  Hillery, Anya M ^a  

^a UNIVERSITY OF BRIGHTON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL TOXIN; DNA VACCINE; DRUG CARRIER; ISCOM; LIPOSOME; SECRETORY IMMUNOGLOBULIN; VACCINE;

DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG UPTAKE; HUMAN; HYDROPHOBICITY; INTRANASAL DRUG ADMINISTRATION; MUCOSAL IMMUNITY; ORAL DRUG ADMINISTRATION; PARTICLE SIZE; RECTAL DRUG ADMINISTRATION; REVIEW; SURFACE PROPERTY; VACCINATION;

EID: 0032077851     PISSN: 14615347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1461-5347(98)00024-8     Document Type: Review

References (69)

1. 1 Lee, V. (1991) in Peptide and Protein Drug Delivery (Lee, V., ed.), pp. 1-57, Marcel Dekker
2. 2 O'Hagan, D.T., Palin, K.J. and Davis, S.S. (1987) Crit. Rev. Ther. Drug Carrier Syst. 4, 197-220
3. 3 Florence, A.T. (1997) Pharm. Res. 14, 259-266
4. 4 O'Hagan, D.T. (1990) Adv. Drug Deliv. Rev. 5, 265-285
5. 5 Hillery, A.M., Jani, P.U. and Florence, A.T. (1994) J. Drug Target. 2, 151-156
6. 6 Gilligan, C.A. and Li Wan Po, A. (1991) Int. J. Pharm. 75, 1-24
7. 7 McGhee, J.R. et al. (1992) Vaccine 10, 75-88
8. 8 Ebel, J.P. (1990) Pharm. Res. 7, 848-851
9. 9 Alpar, H.O. et al. (1989) J. Pharm. Pharmacol. 41, 194-196
10. 10 Jani, P. et al. (1989) J. Pharm. Pharmacol. 41, 809-812
11. 11 Jani, P.U. et al. (1990) J. Pharm. Pharmacol. 42, 821-826
12. 12 LeFevre, M.E., et al. (1978) Experientia 34, 120-122
13. 13 Ebel, J.P. (1990) Pharm. Res. 7, 848-851
14. 14 Eldridge, J.H. et al. (1990) J. Control. Release 11, 205-214
15. 15 Jepson, M.A. et al. (1993) J. Drug Target. 1, 245-249
16. 16 Jepson, M.A. et al. (1993) Cell Tissue Res. 271, 399-405
17. 17 Hillery, A.M. and Florence, A.T. (1996) Int. J. Pharm. 132, 123-130
18. 18 Pappo, J., Ermak, T.H. and Steger, H. (1991) J. Immunol. 73, 277-280
19. 19 Clark, M.A. et al. (1993) J. Histochem. Cytochem. 41, 1679-1687
20. 20 Gebert, A. and Hach, G. (1993) Gostroenterology 105, 1350-1361
21. 21 Hussain, N. and Florence, A.T. (1996) J. Control. Release 41, S3-S4
22. 22 Maincent, P. et al. (1986) J. Pharm. Sci. 10, 965-968
23. 23 Aprahamian, M. et al. (1987) Biol. Cell 61, 69-76
24. 24 Damgé, C. et al. (1988) Diabetes 37, 246-251
25. 25 Russell-Jones, G.J. et al. (1995) Bioconjugate Chem. 6, 34-42
26. 26 Russell-Jones, G.J. et al. (1997) Proc. Int. Symp. Control. Rel. Bioact. Mater. 24, 11-12
27. 27 Steiner, S. and Rosen, R. (1990) US Patent 4 925-673
28. 28 Heiati, H., Phillips, N.C. and Tawashi, R. (1996) Pharm. Res. 13, 1406-1410
29. 29 Muller, R.H. et al. (1997) Pharm. Ind. 59, 423-427
30. 30 Gasco, M.R. et al. (1997) Proc. Int. Symp. Control. Rel. Bioact. Mater. 24, 179-180
31. 31 Hillery, A.M., Toth, I. and Florence, A.T. (1996) J. Control. Release 41, 271-281
32. 32 Hillery, A.M., Toth, I. and Florence, A.T. (1996) J. Control. Release 42, 65-73
33. 33 Hillery, A.M., Toth, I. and Florence, A.T. (1996) Pharm. Sci. 2, 281-283
34. 34 Mathiowitz, E. et al. (1997) Nature 386, 410-414
35. 35 Mestecky, J. (1987) J. Clin. Immunol. 7, 265-276
36. 36 Lavelle, E.C. et al. (1995) Adv. Drug Deliv. Rev. 18, 5-22
37. 37 Wilding, I.R., Davis, S.S. and O'Hagan, D.T. (1994) Pharmacol. Ther. 62, 97-124
38. 38 Lewis, D.H. (1990) in Biodegradable Polymers as Drug Delivery Systems (Chasin, M. and Langer, R., eds), pp. 1-41, Marcel Dekker
39. 39 Challacombe, S.J. et al. (1992) Immunology 76, 164-168
40. 40 Mestecky, J. et al. (1994) J. Control. Release 28, 131-141
41. 41 Marx, P.A. et al. (1993) Science 260, 1323-1327
42. 42 Moldoveanu, Z. et al. (1993) J. Infect. Dis. 167, 84-90
43. 43 Ray, R. et al. (1993) J. Infect. Dis. 167, 752-755
44. 44 O'Hagan, D.T. et al. (1994) Int. J. Pharm. 108, 133-139
45. 45 O'Hagan, D.T., Jeffrey, H. and Davis, S.S. (1993) Vaccine 1, 965-969
46. 46 Maloy, K.J. et al. (1994) Immunology 81, 661-667
47. 47 Bowersock, T.L. et al. (1996) J. Control. Release 39, 209-220
48. 48 Okada, J., Cohen, S. and Langer, R. (1995) Pharm. Res. 12, 576-582
49. 49 Chen, H., Torchilin, V. and Langer, R. (1995) Pharm. Res. 13, 1482-1487
50. 50 Chen, H.M., Torchilin, V. and Langer, R. (1996) Pharm. Res. 13, 1378-1383
51. 51 Chen, H. and Langer, R. (1997) Pharm. Res. 14, 537-540
52. 52 Holmgren, H. and Lycke, N. (1986) in Development of Vaccines and Drugs against Diarrhoea (Holgren, J., Lindberg, A. and Molby R., eds), pp. 9-22, Studentlitterahur, Lund, Sweden
53. 53 Vajdy, M. and Lycke, N.Y. (1992) Immunology 75, 488-492
54. 54 Holmgren J., Lycke, N. and Czerkinsky C. (1993) Vaccine 11, 1179-1184
55. 55 Di Tommaso, A. et al. (1994) Infect. Immun. 64, 974-979
56. 56 Gould-Fogerite, S. and Mannino, R.J. (1996) J. Liposome Res. 6, 357-379
57. 57 Mannino, R.J. and Gould-Fogerite, S. (1995) in Vaccine Design: The Subunit Approach (Powell, M.T. and Newman, M.J., eds), pp. 363-387, Plenum Press
58. 58 Morein, B. et al. (1984) Nature 308, 457-460
59. 59 Mowat, A.M. et al. (1991) Immunology 72, 317-322
60. 60 Jones, D.H. et al. (1997) Vaccine 15, 814-817
61. 61 Toth, I. (1994) J. Drug Target. 2, 217-239
62. 62 Drouillat, B. et al. (1998) J. Pharm. Sci. 87, 25-30
63. 63 Hillery, A.M., Drouillat, B. and Toth, I. (1997) Proc. Int. Symp. Control. Rel. Bioact. Mater. 24, 161-162
64. 64 Shahin, R. et al. (1995) Infect. Immun. 63, 1195-1200
65. 65 Yan, C. (1995) Proc. Int. Symp. Control. Rel. Bioact. Mater. 22, 39-40
66. 66 Ray, R. et al. (1993) Infect. Dis. 167, 752-755
67. 67 Aldeida, A.J., Alpar, H.O. and Brown, M.R.W. (1993) J. Pharm. Pharmacol. 45, 198-203
68. 68 Klavinskis, L.S. et al. (1996) J. Immunol. 157, 2521-2527
69. 69 Zhou, F., Kraehenbuhl, J.P. and Neutra, M.R. (1995) Vaccine 13, 637-644